Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Zai Lab Limited Board/Management Information 2026

Feb 24, 2026

51136_rns_2026-02-24_512573b5-8ed9-437b-b48e-7ffb335dff01.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

{0}------------------------------------------------

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

Zai Lab Limited 再鼎醫藥有限公司*

(incorporated in the Cayman Islands with limited liability) (Stock Code: 9688)

LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS

The members of the board of directors (the "Board") of Zai Lab Limited (the "Company") are set out below.

Director

Dr. Samantha Du (Chairperson and Chief Executive Officer)

Independent directors

Dr. John Diekman (Lead Independent Director)

Dr. Richard Gaynor

Ms. Nisa Leung

Mr. William Lis

Mr. Scott W. Morrison

Mr. Leon O. Moulder, Jr.

Mr. Michel Vounatsos

Mr. Peter Wirth

The Board has five Board committees. The table below provides membership information of these committees on which each director of the Company serves.

Audit
Committee
Compensation
Committee
Nominating and
Corporate
Governance
Committee
Research and
Development
Committee
Commercial
Committee
Dr. Samantha Du M M
Dr. John Diekman M M M
Dr. Richard Gaynor M C
Ms. Nisa Leung M
Mr. William Lis M
Mr. Scott W. Morrison C
Mr. Leon O. Moulder, Jr. C M
Mr. Michel Vounatsos M C
Mr. Peter Wirth M C

Notes:

C Chairperson of the relevant Board committee M Member of the relevant Board committee

February 24, 2026

* For identification only